Recombinant SARS-Cov-2 Spike protein RBD(EG.5), (HEK293), APC Conjugated

Product Overview

• Article Name: Recombinant SARS-Cov-2 Spike protein RBD(EG.5), (HEK293), APC Conjugated
• Biozol Catalog Number: BSS-BS-43196P-APC
• Supplier Catalog Number: bs-43196P-APC
• Alternative Catalog Number: BSS-BS-43196P-APC-20,BSS-BS-43196P-APC-100,BSS-BS-43196P-APC-500
• Manufacturer: Bioss
• Category: Proteine/Peptide
• Species Reactivity: Other
• Conjugation: APC
• Alternative Names: sars-cov-2

Product Description

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

Product Properties

• Tag: C-His
• NCBI: 43740568
• UniProt: P0DTC2
• Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Source: Recombinant SARS-Cov-2 Spike protein RBD(EG.5) is expressed in HEK293 cell with C-His. It contains the amino acid sequence of 319-537/1273
• Expression System: HEK293
• Purity: > 90% as determined by SDS- PAGE